Novo Nordisk A/S NVO reported fourth-quarter 2016 earnings of 50 cents per American Depositary Receipt (ADR), missing the Zacks Consensus Estimate of 52 cents by 3.8%. Reported earnings, however, surpassed the year ago figure of 48 cents. Quarterly revenues were up 1.2%
Read more